• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
Citation: WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303

Advances in research of biomimetic drug delivery systems

More Information
  • Biomimetic drug delivery systems(BDDSs)based on natural particulate carriers possess good targeting ability and low immunogenicity, and are emerging drug delivery systems with great development potential in recent years. This review presents an overview of the latest advances in biomimetic drug delivery systems, concerning mammalian cells, endogenous proteins and pathogens.
  • [1]
    Stanley S.Biological nanoparticles and their influence on organisms[J]. Curr Opin Biotechnol,2014(28):69-74.
    [2]
    Roth J,Curiel D,Pereboeva L.Cell vehicle targeting strategies[J]. Gene Ther,2008,15(10):716-729.
    [3]
    Hamidi M,Zarrin A,Foroozesh M,et al.Applications of carrier erythrocytes in delivery of biopharmaceuticals[J]. J Control Release,2007,118(2):145-160.
    [4]
    Muzykantov VR.Drug delivery carriers on the fringes:natural red blood cells versus synthetic multilayered capsules[J]. Expert Opin Drug Deliv,2013,10(1):1-4.
    [5]
    Anbharasi V,Cao N,Feng SS.Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy[J]. J Biomel Mater Res A,2010,94(3):730-743.
    [6]
    Gopal V,Kumar AR,Usha N,et al.Effective drug targeting by erythrocytes as carrier systems[J]. Curr Trends Biotechnol Pharm,2007,(1):18-33.
    [7]
    Chambers E,Mitragotri S.Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes[J]. J Control Release,2004,100(1):111-119.
    [8]
    Chambers E, Mitragotri S. Long circulating nanoparticles via adhesion on red blood cells:mechanism and extended circulation[J]. Exp Biol Med,2007,232(7):958-966.
    [9]
    Cinti C,Taranta M,Naldi I,et al.Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds[J]. PLoS One,2011,6(2):e17132.
    [10]
    Wang LY,Shi XY,Yang CS,et al.Versatile RBC-derived vesicles as nanoparticle vector of photosensitizers for photodynamic therapy[J]. Nanoscale,2013,5(1):416-421.
    [11]
    Mantovani A,Sozzani S,Locati M,et al.Macrophage polarization:tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes[J]. Trends Immunol,2002,23(11):549-555.
    [12]
    Peng KW,Dogan A,Vrana J,et al.Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma[J]. Am J Hematol,2009,84(7):401-407.
    [13]
    Choi MR,Bardhan R,Stanton-Maxey KJ,et al.Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse[J]. Cancer Nanotechnol,2012,3(1-6):47-54.
    [14]
    Alizadeh D,Zhang L,Hwang J,et al.Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas[J]. Nanomedicine,2010,6(2):382-390.
    [15]
    Swiston AJ,Cheng C,Um SH,et al.Surface functionalization of living cells with multilayer patches[J]. Nano Lett,2008,8(12):4 446-4 453.
    [16]
    Stephan MT,Moon JJ,Um SH,et al.Therapeutic cell engineering with surface-conjugated synthetic nanoparticles[J]. Nat Med,2010,16(9):1 035-1 041.
    [17]
    Kosaka H,Ichikawa T,Kurozumi K,et al.Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma[J]. Cancer Gene Ther,2012,19(8):572-578.
    [18]
    Bak X, Yang J, Wang S. Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy[J]. Cancer Gene Ther,2010,17(10):721-729.
    [19]
    Huang Q,Liu X,Kang C,et al.The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells[J]. Cancer Gene Ther,2009,17(3):192-202.
    [20]
    Nakamura K,Ito Y,Kawano Y,et al.Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model[J]. Gene Ther,2004,11(14):1 155-1 164.
    [21]
    Ren C,Kumar S,Chanda D,et al.汃敡楮捣?慲挠楧摥?摥攠汴楨癥敲牡祰孹?嵵??楮??乭慥湳潥??敨瑹瑭??椠???ねㄠ???扬?ㄠ???扲????????の?????????抲爠??嬠?ㄠ嵭?創敳祥渠潰汲摯獳?????畣污楮正?割匠??坮敧渠?塥?楡???敳瑩?愠汭????楛??漮眼?搾攠湇獥楮瑥礠?汨楥灲漼瀯物漾琬攲椰渰?洬攼摢椾愱琵攼搯?搾攨氲椱瘩攺爱礠?漴昶?搱漠挴漵猳愮格敢硲愯放湛漲椲捝?慈捵椠摙?猬效汵敡据瑧椠療攬汚票?歮楧氠汔獙?浩甾爬楥湴攠?汬椮瘼支物 ̄捍慥湳捥敮牣?捹敭污汬猠孳?嵥??楣??乬慳渠潡浳攠摡椠据楯湶敥??潣湡摲???楲???ひㄠ??孲?灥畴扥?愠桤敥慬摩?潥晲?瀠牯楦渠瑧嵥??戠物??季??嵣??甠湴瑨潥獲潡癰慹?噢??略穤漠癯慮???偮敶瑩牲潡癬愠橴潲癡慮???楣??敯瑮?慊汝???椾??敯癬攠汐潨灡浲敭渼琯?漾昬′愰?渲攬眼?????扢愾猨改搩?琲爠愶渹猸瀭漲爠琷‰猹礮猼瑢敲洯 ̄晛漲爳?栠祍摡爠潇瀬桚潨扵椠捘?慘浵灡桮椠灓格楩氾椬捥?搠牡畬朮?搯敩氾楓癴敵牤祹?瑯潦?捩慮湨捩敢物?捩敮汧氠獡孮?崠??楬???湧琠???健档慴牳洠??椠???の????扩??????扴????????????????戠牣??孤??嵬??潤瀠敭捥歳慥????慭浡灬椠慳???传汣楥癬敬牳漠?偮?楳??敭瑡?慨氠???楣???????浩愾猠歃敨摩?氠楊瀠潇獡潳浴慲汯?摮潴硥潳牴甠打極捲楧渼?物放瘨攭牎珃斠猖?摂狗甩本′爰攱猲椬猼瑢愾渱挵攼?楢渾?栱由洩愺渱?挱愷游挭攱爠?挸攱氮氼獢孲?崾??椴?????潧渠瑑爬潚汨?剮敧氠敓愬獙敡??椠????????扡??????扐??????????ぬ???扩牮??孯??嵮??歡椠湰???卥瑣畴物杶楥猠???剴慩杮桧攠扦???楮??敯瑰?慲汴???楥??慢捡瑳敥牤椠慤?浵敧搠楤慥瑬敩摶?摲敹氠楳癹敳牴祥?潛晊?渮愼湩漾瀠慂物瑯業捡汴敥獲?慡湬摳?振慩爾本漲‰椱渳琬漼?挾攳水氼猯孢?崨??椩??丠愵琲?中愸渠漵琳攰挮格湢潲氯??椲??㈠がど???扚????戠??????????????扡牬??嬯??嵐?呥慰污敲扡歴桩慯湮?奡??愠扣慨扡敲楡正????獺浡慴敩楯汮椠???楧??敡瑣?慯汳???楴??攠汢楯捶潩扮慥挠瑳敥牲?灭礠污潬牢極?扩慮挠瑮敡牮楯慰污?杴桩潣獬瑥?挠潦湯瑲愠楬湩楶湥杲?牴敡捲潧浥扴楥湤愠湤瑥?佩浶灥???慯獦?慯?灩畤瑯慮瑩楮癛敊?瘮愼捩挾椠湉敮孴?嵊??楨?????楩挾爬漲戰椱漳氬??放琴栴漸搼猯??椨??呼?????戮?????扛??????????????扯牴??孥??嵥?圠畆?坁??獯楲慮漠?升???愬牥牴椠捡潬?娼??椾??敨瑡?慣汥???楲??攠湴潡浲敧?晴物敮敧?癢楹爠慡汴?捡慣灨獭楥摮獴?慯獦?浡畮氠瑡楮癴慩氠斱湶琠?据慴牥牧楲敩牮猠?普潴物?瑯慤硹漠汴?搠敤汯楸癯敲牵祢孩?嵩??楬???湥杤攠睨??桡敮洠??湲瑵??摡??湵杭汩??楮???ばち???扣?????扝??????????????????/i>,2010,31(8):2 388-2 398.
    [22]
    Liu CY,Wang W,Zhou JP,et al.Study on preparation and properties of gambogic acid-loaded reconstituted high density lipoprotein nanoparticles[J]. J China Pharm Univ(中国药科大学学报),2013,44(4):311-315.
    [23]
    Ding Y,Wang W,Feng M,et al.A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy[J]. Biomaterials,2012,33(34):8 893-8 905.
    [24]
    Zhang M,Jia J,Liu J,et al.A novel modified paclitaxel-loaded discoidal recombinant high-density lipoproteins:preparation,characterizations and in vivo evaluation[J]. AJPS(亚洲药物制剂科学),2013,8(1):11-18.
    [25]
    McMahon KM,Mutharasan RK,Tripathy S,et al.Biomimetic high density lipoprotein nanoparticles for nuc
  • Related Articles

    [1]YANG Qian, WANG Xiaojian. Research progress of sphingosine kinase 1 inhibitors[J]. Journal of China Pharmaceutical University, 2021, 52(6): 759-768. DOI: 10.11665/j.issn.1000-5048.20210615
    [2]LI Yin, GU Hongfeng, ZOU Yi, WANG Shuping, XU Yungen. Research progress of mono-(ADP-ribosyl) transferase family and their inhibitors in tumor therapy[J]. Journal of China Pharmaceutical University, 2021, 52(6): 643-652. DOI: 10.11665/j.issn.1000-5048.20210601
    [3]BU Hong, ZHOU Jinpei, ZHANG Huibin. Research progress of mitogen-activated protein kinase interacting kinases inhibitors in tumor immunotherapy[J]. Journal of China Pharmaceutical University, 2021, 52(4): 410-421. DOI: 10.11665/j.issn.1000-5048.20210403
    [4]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [5]TIAN Jiping, ZHANG Jian, ZHOU Jinpei, ZHANG Huibin. Advances in small molecule inhibitors of PD-1/PD-L1 immune checkpoint pathway[J]. Journal of China Pharmaceutical University, 2019, 50(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20190101
    [6]LIU Kejun, ZHANG Zhimin, RAN Ting, CHEN Hongli, LU Tao, CHEN Yadong. Advances in BET bromodomain protein inhibitors[J]. Journal of China Pharmaceutical University, 2015, 46(3): 264-271. DOI: 10.11665/j.issn.1000-5048.20150302
    [7]ZHANG Yuan, CHENG Yulan, ZHOU Jinpei, ZHANG Huibin. Advances on receptor tyrosine kinase inhibitors taking c-Met as anti-tumor target[J]. Journal of China Pharmaceutical University, 2015, 46(1): 16-27. DOI: 10.11665/j.issn.1000-5048.20150102
    [8]LI Chunhong, DU Hongjin, WEN Xiao′an, SUN Hongbin. Advances in inhibitors of MDM2 and MDM4[J]. Journal of China Pharmaceutical University, 2015, 46(1): 1-15. DOI: 10.11665/j.issn.1000-5048.20150101
    [9]DENG Lian-bai, LI Ai-xiu, JIN Yu-rui. Advances in the study on inhibitors of RNase H,a novel anti-HIV drug target[J]. Journal of China Pharmaceutical University, 2011, 42(6): 578-584.
    [10]KONG Kai-lai, LU Shuai, GAO Yi-ping, YANG Pei, TANG Wei-fang, LU Tao. Advances on the study of PLK1 inhibitors as antitumor agents[J]. Journal of China Pharmaceutical University, 2011, 42(1): 9-15.
  • Cited by

    Periodical cited type(2)

    1. 郁莉,蒋颖敏,许磊,朱景宇. 分子对接与分子动力学模拟法探究PI3Kδ/度维利塞(Duvelisib)的选择性结合. 化学研究与应用. 2022(02): 341-348 .
    2. 蔡燕飞,陈蕴,史劲松,金坚. 抗肿瘤药物体外药效学评价结合细胞生物学实验教学促进教研融合. 实验室研究与探索. 2020(08): 192-195 .

    Other cited types(0)

Catalog

    Article views (1969) PDF downloads (3431) Cited by(2)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return